Perspectives on Cancer Genome Profiling


Liquid Biopsy: Addressing the need, when tissue is an issue

For oncologists, molecular testing of tissue biopsies currently remains the gold standard for best understanding a patient’s disease and recommending treatment modalities. Unfortunately, there are multiple scenarios where tissue is not available or of sufficient quantity and quality for testing. For example, 10-25% of NSCLC patients may have an insufficient tissue for…